NM_021160.3:c.190-178T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_021160.3(ABHD16A):c.190-178T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.048 in 152,292 control chromosomes in the GnomAD database, including 325 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.048 ( 325 hom., cov: 32)
Consequence
ABHD16A
NM_021160.3 intron
NM_021160.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.628
Publications
21 publications found
Genes affected
ABHD16A (HGNC:13921): (abhydrolase domain containing 16A, phospholipase) A cluster of genes, BAT1-BAT5, has been localized in the vicinity of the genes for tumor necrosis factor alpha and tumor necrosis factor beta. These genes are all within the human major histocompatibility complex class III region. The protein encoded by this gene is thought to be involved in some aspects of immunity. Alternatively spliced transcript variants have been described. [provided by RefSeq, Apr 2010]
ABHD16A Gene-Disease associations (from GenCC):
- spastic paraplegia 86, autosomal recessiveInheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.201 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ABHD16A | NM_021160.3 | c.190-178T>C | intron_variant | Intron 2 of 19 | ENST00000395952.8 | NP_066983.1 | ||
| ABHD16A | NM_001177515.2 | c.158-490T>C | intron_variant | Intron 1 of 17 | NP_001170986.1 | |||
| ABHD16A | NR_033488.2 | n.405-178T>C | intron_variant | Intron 2 of 19 | ||||
| ABHD16A | NR_033489.2 | n.176-490T>C | intron_variant | Intron 1 of 17 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0480 AC: 7307AN: 152174Hom.: 325 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
7307
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0480 AC: 7305AN: 152292Hom.: 325 Cov.: 32 AF XY: 0.0493 AC XY: 3673AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
7305
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
3673
AN XY:
74472
show subpopulations
African (AFR)
AF:
AC:
429
AN:
41574
American (AMR)
AF:
AC:
497
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
208
AN:
3470
East Asian (EAS)
AF:
AC:
1093
AN:
5166
South Asian (SAS)
AF:
AC:
595
AN:
4826
European-Finnish (FIN)
AF:
AC:
350
AN:
10614
Middle Eastern (MID)
AF:
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3874
AN:
68018
Other (OTH)
AF:
AC:
98
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
332
665
997
1330
1662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
424
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.